157 related articles for article (PubMed ID: 24331653)
1. Local recurrence in women with stage I breast cancer: declining rates over time in a large, population-based cohort.
Canavan J; Truong PT; Smith SL; Lu L; Lesperance M; Olivotto IA
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):80-6. PubMed ID: 24331653
[TBL] [Abstract][Full Text] [Related]
2. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy.
Lupe K; Truong PT; Alexander C; Lesperance M; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e561-8. PubMed ID: 21514069
[TBL] [Abstract][Full Text] [Related]
3. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
[TBL] [Abstract][Full Text] [Related]
4. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
5. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
[TBL] [Abstract][Full Text] [Related]
6. Identification of patients at very low risk of local recurrence after breast-conserving surgery.
Smith SL; Truong PT; Lu L; Lesperance M; Olivotto IA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):556-62. PubMed ID: 24929165
[TBL] [Abstract][Full Text] [Related]
7. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome following breast-conserving surgery and radiation therapy.
Gage I; Recht A; Gelman R; Nixon AJ; Silver B; Bornstein BA; Harris JR
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):245-51. PubMed ID: 7673011
[TBL] [Abstract][Full Text] [Related]
9. Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Russo AL; Arvold ND; Niemierko A; Wong N; Wong JS; Bellon JR; Punglia RS; Golshan M; Troyan SL; Brock JE; Harris JR
Breast Cancer Res Treat; 2013 Jul; 140(2):353-61. PubMed ID: 23836011
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.
van Laar C; van der Sangen MJ; Poortmans PM; Nieuwenhuijzen GA; Roukema JA; Roumen RM; Tjan-Heijnen VC; Voogd AC
Eur J Cancer; 2013 Oct; 49(15):3093-101. PubMed ID: 23800672
[TBL] [Abstract][Full Text] [Related]
11. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?
Vicini FA; Kestin L; Huang R; Martinez A
Cancer; 2003 Feb; 97(4):910-9. PubMed ID: 12569590
[TBL] [Abstract][Full Text] [Related]
12. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
13. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age.
Miles RC; Gullerud RE; Lohse CM; Jakub JW; Degnim AC; Boughey JC
Ann Surg Oncol; 2012 Apr; 19(4):1153-9. PubMed ID: 21989658
[TBL] [Abstract][Full Text] [Related]
15. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
16. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation.
Panoff JE; Hurley J; Takita C; Reis IM; Zhao W; Sujoy V; Gomez CR; Jorda M; Koniaris L; Wright JL
Breast Cancer Res Treat; 2011 Aug; 128(3):899-906. PubMed ID: 21475999
[TBL] [Abstract][Full Text] [Related]
17. Negative margin status improves local control in conservatively managed breast cancer patients.
Obedian E; Haffty BG
Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
[TBL] [Abstract][Full Text] [Related]
18. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
[TBL] [Abstract][Full Text] [Related]
19. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
20. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
